Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil

Abstract Study Objective To compare the effects of aminophylline and doxapram on recovery, respiration, and bispectral index (BIS) values in patients after total intravenous anesthesia (TIVA) with propofol and remifentanil. Design Prospective, randomized, blinded clinical trial. Setting Operating ro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical anesthesia 2013-05, Vol.25 (3), p.173-176
Hauptverfasser: Kim, Dae Woo, MD, PhD, Joo, Jin Deok, MD, PhD, In, Jang Hyeok, MD, PhD, Jeon, Yeon Su, MD, PhD, Jung, Hong Soo, MD, Jeon, Kyeong Bae, MD, Park, Jae Sik, MD, Choi, Jin Woo, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 176
container_issue 3
container_start_page 173
container_title Journal of clinical anesthesia
container_volume 25
creator Kim, Dae Woo, MD, PhD
Joo, Jin Deok, MD, PhD
In, Jang Hyeok, MD, PhD
Jeon, Yeon Su, MD, PhD
Jung, Hong Soo, MD
Jeon, Kyeong Bae, MD
Park, Jae Sik, MD
Choi, Jin Woo, MD, PhD
description Abstract Study Objective To compare the effects of aminophylline and doxapram on recovery, respiration, and bispectral index (BIS) values in patients after total intravenous anesthesia (TIVA) with propofol and remifentanil. Design Prospective, randomized, blinded clinical trial. Setting Operating room of a university hospital. Patients 90 adult, ASA physical status 1 and 2 patients scheduled for elective laparoscopic vaginal hysterectomy. Interventions TIVA was performed with the induction target of remifentanil 3 ng/mL and propofol 6 μg/mL, followed by the maintenance target of remifentanil 1–3 ng/mL and propofol 3–5 μg/mL at the effect site, and with BIS scores in 40–50 range. Patients were randomized to three groups to receive intravenous (IV) aminophylline 3 mg/kg (n = 30), IV doxapram 1 mg/kg (n = 30), or normal IV saline (control; n = 30). Measurements and Main Results After administration of the study drugs, return to spontaneous ventilation differed significantly among the three groups. The times to eye opening and hand squeezing on verbal command were similar. The time to extubation was shortened in both the doxapram and aminophylline groups ( P < 0.05). Tidal volumes were increased in the doxapram group at 5–14 minutes and the aminophylline group at 5–12 minutes ( P < 0.05). Respiratory rates were increased at 2 to 8 minutes and then showed a decrease at the 12 to 14-minute mark in both the doxapram and aminophylline groups ( P < 0.05). No difference was noted between the two groups. BIS values were increased in both the doxapram and aminophylline groups at 4–10 minutes ( P < 0.05). Heart rates were increased in the doxapram group for the first 8 minutes and at 1–2 minutes in the aminophylline group ( P < 0.05). Conclusion Aminophylline 3 mg/kg or doxapram 1 mg/kg shortened the time to spontaneous ventilation and improved early recovery from TIVA without appreciable side effects. The more rapid emergence correlates with higher BIS values when compared with the saline control group. The arousal and respiratory effects of aminophylline were comparable to those of doxapram.
doi_str_mv 10.1016/j.jclinane.2012.07.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1827910176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S095281801300055X</els_id><sourcerecordid>1353986455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-9ae4b04f75030395675c343066a26e7e93e4dbecee2dd1462535b96419ace9163</originalsourceid><addsrcrecordid>eNqNks-K1EAQxoMo7rj6CktABC-J_TdJX0QZdBUWPKjgrenpVJyOSXfszsw6L-LzWtmZdWEvemqK_lXVV_VVll1QUlJCq1d92dvBeeOhZISyktQlIfJBtqJNzQshmXqYrYiSrGhoQ86yJyn1hBD8oI-zM8Zlw4VsVtnvdRgnE10KPg9dPm8hj2DDHuIhN77FIE0umjlgDF0Hdk4LZ0bnw7Q9DKgBbsA2_DJTNGPehWEI185_z-cwmyF3fo5mDz7sEoKQsEVyJr928zafYpgCJpxaja4DPxvvhqfZo84MCZ6d3vPs6_t3X9YfiqtPlx_Xb68KK6mYC2VAbIjoakk44UpWtbRccFJVhlVQg-Ig2g1YANa2VFRMcrlRlaDKWFC04ufZy2NdVPJzh-L06JKFYUClKFjThtUKF17_B8olV00lpET0-T20D7vocZCFkkpyphhS1ZGyMaQUodNTdKOJB02JXkzWvb41WS8ma1JrNBkTL07ld5sR2r9pt64i8OIEmGTN0EXjrUt3XC2YEmop9ObIAa547yDqZB14C63DI5h1G9y_tby-V2KhHHb9AQdId3PrhDn683KSy0VSjtco5Tf-B-pw4Bc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1355953292</pqid></control><display><type>article</type><title>Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Kim, Dae Woo, MD, PhD ; Joo, Jin Deok, MD, PhD ; In, Jang Hyeok, MD, PhD ; Jeon, Yeon Su, MD, PhD ; Jung, Hong Soo, MD ; Jeon, Kyeong Bae, MD ; Park, Jae Sik, MD ; Choi, Jin Woo, MD, PhD</creator><creatorcontrib>Kim, Dae Woo, MD, PhD ; Joo, Jin Deok, MD, PhD ; In, Jang Hyeok, MD, PhD ; Jeon, Yeon Su, MD, PhD ; Jung, Hong Soo, MD ; Jeon, Kyeong Bae, MD ; Park, Jae Sik, MD ; Choi, Jin Woo, MD, PhD</creatorcontrib><description>Abstract Study Objective To compare the effects of aminophylline and doxapram on recovery, respiration, and bispectral index (BIS) values in patients after total intravenous anesthesia (TIVA) with propofol and remifentanil. Design Prospective, randomized, blinded clinical trial. Setting Operating room of a university hospital. Patients 90 adult, ASA physical status 1 and 2 patients scheduled for elective laparoscopic vaginal hysterectomy. Interventions TIVA was performed with the induction target of remifentanil 3 ng/mL and propofol 6 μg/mL, followed by the maintenance target of remifentanil 1–3 ng/mL and propofol 3–5 μg/mL at the effect site, and with BIS scores in 40–50 range. Patients were randomized to three groups to receive intravenous (IV) aminophylline 3 mg/kg (n = 30), IV doxapram 1 mg/kg (n = 30), or normal IV saline (control; n = 30). Measurements and Main Results After administration of the study drugs, return to spontaneous ventilation differed significantly among the three groups. The times to eye opening and hand squeezing on verbal command were similar. The time to extubation was shortened in both the doxapram and aminophylline groups ( P &lt; 0.05). Tidal volumes were increased in the doxapram group at 5–14 minutes and the aminophylline group at 5–12 minutes ( P &lt; 0.05). Respiratory rates were increased at 2 to 8 minutes and then showed a decrease at the 12 to 14-minute mark in both the doxapram and aminophylline groups ( P &lt; 0.05). No difference was noted between the two groups. BIS values were increased in both the doxapram and aminophylline groups at 4–10 minutes ( P &lt; 0.05). Heart rates were increased in the doxapram group for the first 8 minutes and at 1–2 minutes in the aminophylline group ( P &lt; 0.05). Conclusion Aminophylline 3 mg/kg or doxapram 1 mg/kg shortened the time to spontaneous ventilation and improved early recovery from TIVA without appreciable side effects. The more rapid emergence correlates with higher BIS values when compared with the saline control group. The arousal and respiratory effects of aminophylline were comparable to those of doxapram.</description><identifier>ISSN: 0952-8180</identifier><identifier>EISSN: 1873-4529</identifier><identifier>DOI: 10.1016/j.jclinane.2012.07.005</identifier><identifier>PMID: 23583458</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aminophylline ; Aminophylline - pharmacology ; Anesthesia ; Anesthesia &amp; Perioperative Care ; Anesthesia Recovery Period ; Anesthesia, Intravenous - methods ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anesthetics, Intravenous - administration &amp; dosage ; Biological and medical sciences ; Bispectral index monitoring ; Bronchodilator Agents - pharmacology ; Double-Blind Method ; Doxapram ; Doxapram - pharmacology ; Drug dosages ; Electroencephalography - drug effects ; Female ; Heart rate ; Heart Rate - drug effects ; Humans ; Hysterectomy, Vaginal ; Medical sciences ; Middle Aged ; Monitoring systems ; Pain Medicine ; Patients ; Piperidines - administration &amp; dosage ; Propofol ; Propofol - administration &amp; dosage ; Remifentanil ; Respiration - drug effects ; Respiratory System Agents - pharmacology ; Surgery ; Tidal Volume - drug effects ; Total intravenous anesthesia</subject><ispartof>Journal of clinical anesthesia, 2013-05, Vol.25 (3), p.173-176</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-9ae4b04f75030395675c343066a26e7e93e4dbecee2dd1462535b96419ace9163</citedby><cites>FETCH-LOGICAL-c514t-9ae4b04f75030395675c343066a26e7e93e4dbecee2dd1462535b96419ace9163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1355953292?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27429495$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23583458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Dae Woo, MD, PhD</creatorcontrib><creatorcontrib>Joo, Jin Deok, MD, PhD</creatorcontrib><creatorcontrib>In, Jang Hyeok, MD, PhD</creatorcontrib><creatorcontrib>Jeon, Yeon Su, MD, PhD</creatorcontrib><creatorcontrib>Jung, Hong Soo, MD</creatorcontrib><creatorcontrib>Jeon, Kyeong Bae, MD</creatorcontrib><creatorcontrib>Park, Jae Sik, MD</creatorcontrib><creatorcontrib>Choi, Jin Woo, MD, PhD</creatorcontrib><title>Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil</title><title>Journal of clinical anesthesia</title><addtitle>J Clin Anesth</addtitle><description>Abstract Study Objective To compare the effects of aminophylline and doxapram on recovery, respiration, and bispectral index (BIS) values in patients after total intravenous anesthesia (TIVA) with propofol and remifentanil. Design Prospective, randomized, blinded clinical trial. Setting Operating room of a university hospital. Patients 90 adult, ASA physical status 1 and 2 patients scheduled for elective laparoscopic vaginal hysterectomy. Interventions TIVA was performed with the induction target of remifentanil 3 ng/mL and propofol 6 μg/mL, followed by the maintenance target of remifentanil 1–3 ng/mL and propofol 3–5 μg/mL at the effect site, and with BIS scores in 40–50 range. Patients were randomized to three groups to receive intravenous (IV) aminophylline 3 mg/kg (n = 30), IV doxapram 1 mg/kg (n = 30), or normal IV saline (control; n = 30). Measurements and Main Results After administration of the study drugs, return to spontaneous ventilation differed significantly among the three groups. The times to eye opening and hand squeezing on verbal command were similar. The time to extubation was shortened in both the doxapram and aminophylline groups ( P &lt; 0.05). Tidal volumes were increased in the doxapram group at 5–14 minutes and the aminophylline group at 5–12 minutes ( P &lt; 0.05). Respiratory rates were increased at 2 to 8 minutes and then showed a decrease at the 12 to 14-minute mark in both the doxapram and aminophylline groups ( P &lt; 0.05). No difference was noted between the two groups. BIS values were increased in both the doxapram and aminophylline groups at 4–10 minutes ( P &lt; 0.05). Heart rates were increased in the doxapram group for the first 8 minutes and at 1–2 minutes in the aminophylline group ( P &lt; 0.05). Conclusion Aminophylline 3 mg/kg or doxapram 1 mg/kg shortened the time to spontaneous ventilation and improved early recovery from TIVA without appreciable side effects. The more rapid emergence correlates with higher BIS values when compared with the saline control group. The arousal and respiratory effects of aminophylline were comparable to those of doxapram.</description><subject>Adult</subject><subject>Aminophylline</subject><subject>Aminophylline - pharmacology</subject><subject>Anesthesia</subject><subject>Anesthesia &amp; Perioperative Care</subject><subject>Anesthesia Recovery Period</subject><subject>Anesthesia, Intravenous - methods</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anesthetics, Intravenous - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Bispectral index monitoring</subject><subject>Bronchodilator Agents - pharmacology</subject><subject>Double-Blind Method</subject><subject>Doxapram</subject><subject>Doxapram - pharmacology</subject><subject>Drug dosages</subject><subject>Electroencephalography - drug effects</subject><subject>Female</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Hysterectomy, Vaginal</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring systems</subject><subject>Pain Medicine</subject><subject>Patients</subject><subject>Piperidines - administration &amp; dosage</subject><subject>Propofol</subject><subject>Propofol - administration &amp; dosage</subject><subject>Remifentanil</subject><subject>Respiration - drug effects</subject><subject>Respiratory System Agents - pharmacology</subject><subject>Surgery</subject><subject>Tidal Volume - drug effects</subject><subject>Total intravenous anesthesia</subject><issn>0952-8180</issn><issn>1873-4529</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNks-K1EAQxoMo7rj6CktABC-J_TdJX0QZdBUWPKjgrenpVJyOSXfszsw6L-LzWtmZdWEvemqK_lXVV_VVll1QUlJCq1d92dvBeeOhZISyktQlIfJBtqJNzQshmXqYrYiSrGhoQ86yJyn1hBD8oI-zM8Zlw4VsVtnvdRgnE10KPg9dPm8hj2DDHuIhN77FIE0umjlgDF0Hdk4LZ0bnw7Q9DKgBbsA2_DJTNGPehWEI185_z-cwmyF3fo5mDz7sEoKQsEVyJr928zafYpgCJpxaja4DPxvvhqfZo84MCZ6d3vPs6_t3X9YfiqtPlx_Xb68KK6mYC2VAbIjoakk44UpWtbRccFJVhlVQg-Ig2g1YANa2VFRMcrlRlaDKWFC04ufZy2NdVPJzh-L06JKFYUClKFjThtUKF17_B8olV00lpET0-T20D7vocZCFkkpyphhS1ZGyMaQUodNTdKOJB02JXkzWvb41WS8ma1JrNBkTL07ld5sR2r9pt64i8OIEmGTN0EXjrUt3XC2YEmop9ObIAa547yDqZB14C63DI5h1G9y_tby-V2KhHHb9AQdId3PrhDn683KSy0VSjtco5Tf-B-pw4Bc</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Kim, Dae Woo, MD, PhD</creator><creator>Joo, Jin Deok, MD, PhD</creator><creator>In, Jang Hyeok, MD, PhD</creator><creator>Jeon, Yeon Su, MD, PhD</creator><creator>Jung, Hong Soo, MD</creator><creator>Jeon, Kyeong Bae, MD</creator><creator>Park, Jae Sik, MD</creator><creator>Choi, Jin Woo, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130501</creationdate><title>Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil</title><author>Kim, Dae Woo, MD, PhD ; Joo, Jin Deok, MD, PhD ; In, Jang Hyeok, MD, PhD ; Jeon, Yeon Su, MD, PhD ; Jung, Hong Soo, MD ; Jeon, Kyeong Bae, MD ; Park, Jae Sik, MD ; Choi, Jin Woo, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-9ae4b04f75030395675c343066a26e7e93e4dbecee2dd1462535b96419ace9163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aminophylline</topic><topic>Aminophylline - pharmacology</topic><topic>Anesthesia</topic><topic>Anesthesia &amp; Perioperative Care</topic><topic>Anesthesia Recovery Period</topic><topic>Anesthesia, Intravenous - methods</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anesthetics, Intravenous - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Bispectral index monitoring</topic><topic>Bronchodilator Agents - pharmacology</topic><topic>Double-Blind Method</topic><topic>Doxapram</topic><topic>Doxapram - pharmacology</topic><topic>Drug dosages</topic><topic>Electroencephalography - drug effects</topic><topic>Female</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Hysterectomy, Vaginal</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring systems</topic><topic>Pain Medicine</topic><topic>Patients</topic><topic>Piperidines - administration &amp; dosage</topic><topic>Propofol</topic><topic>Propofol - administration &amp; dosage</topic><topic>Remifentanil</topic><topic>Respiration - drug effects</topic><topic>Respiratory System Agents - pharmacology</topic><topic>Surgery</topic><topic>Tidal Volume - drug effects</topic><topic>Total intravenous anesthesia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Dae Woo, MD, PhD</creatorcontrib><creatorcontrib>Joo, Jin Deok, MD, PhD</creatorcontrib><creatorcontrib>In, Jang Hyeok, MD, PhD</creatorcontrib><creatorcontrib>Jeon, Yeon Su, MD, PhD</creatorcontrib><creatorcontrib>Jung, Hong Soo, MD</creatorcontrib><creatorcontrib>Jeon, Kyeong Bae, MD</creatorcontrib><creatorcontrib>Park, Jae Sik, MD</creatorcontrib><creatorcontrib>Choi, Jin Woo, MD, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of clinical anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Dae Woo, MD, PhD</au><au>Joo, Jin Deok, MD, PhD</au><au>In, Jang Hyeok, MD, PhD</au><au>Jeon, Yeon Su, MD, PhD</au><au>Jung, Hong Soo, MD</au><au>Jeon, Kyeong Bae, MD</au><au>Park, Jae Sik, MD</au><au>Choi, Jin Woo, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil</atitle><jtitle>Journal of clinical anesthesia</jtitle><addtitle>J Clin Anesth</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>25</volume><issue>3</issue><spage>173</spage><epage>176</epage><pages>173-176</pages><issn>0952-8180</issn><eissn>1873-4529</eissn><abstract>Abstract Study Objective To compare the effects of aminophylline and doxapram on recovery, respiration, and bispectral index (BIS) values in patients after total intravenous anesthesia (TIVA) with propofol and remifentanil. Design Prospective, randomized, blinded clinical trial. Setting Operating room of a university hospital. Patients 90 adult, ASA physical status 1 and 2 patients scheduled for elective laparoscopic vaginal hysterectomy. Interventions TIVA was performed with the induction target of remifentanil 3 ng/mL and propofol 6 μg/mL, followed by the maintenance target of remifentanil 1–3 ng/mL and propofol 3–5 μg/mL at the effect site, and with BIS scores in 40–50 range. Patients were randomized to three groups to receive intravenous (IV) aminophylline 3 mg/kg (n = 30), IV doxapram 1 mg/kg (n = 30), or normal IV saline (control; n = 30). Measurements and Main Results After administration of the study drugs, return to spontaneous ventilation differed significantly among the three groups. The times to eye opening and hand squeezing on verbal command were similar. The time to extubation was shortened in both the doxapram and aminophylline groups ( P &lt; 0.05). Tidal volumes were increased in the doxapram group at 5–14 minutes and the aminophylline group at 5–12 minutes ( P &lt; 0.05). Respiratory rates were increased at 2 to 8 minutes and then showed a decrease at the 12 to 14-minute mark in both the doxapram and aminophylline groups ( P &lt; 0.05). No difference was noted between the two groups. BIS values were increased in both the doxapram and aminophylline groups at 4–10 minutes ( P &lt; 0.05). Heart rates were increased in the doxapram group for the first 8 minutes and at 1–2 minutes in the aminophylline group ( P &lt; 0.05). Conclusion Aminophylline 3 mg/kg or doxapram 1 mg/kg shortened the time to spontaneous ventilation and improved early recovery from TIVA without appreciable side effects. The more rapid emergence correlates with higher BIS values when compared with the saline control group. The arousal and respiratory effects of aminophylline were comparable to those of doxapram.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>23583458</pmid><doi>10.1016/j.jclinane.2012.07.005</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0952-8180
ispartof Journal of clinical anesthesia, 2013-05, Vol.25 (3), p.173-176
issn 0952-8180
1873-4529
language eng
recordid cdi_proquest_miscellaneous_1827910176
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Aminophylline
Aminophylline - pharmacology
Anesthesia
Anesthesia & Perioperative Care
Anesthesia Recovery Period
Anesthesia, Intravenous - methods
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anesthetics, Intravenous - administration & dosage
Biological and medical sciences
Bispectral index monitoring
Bronchodilator Agents - pharmacology
Double-Blind Method
Doxapram
Doxapram - pharmacology
Drug dosages
Electroencephalography - drug effects
Female
Heart rate
Heart Rate - drug effects
Humans
Hysterectomy, Vaginal
Medical sciences
Middle Aged
Monitoring systems
Pain Medicine
Patients
Piperidines - administration & dosage
Propofol
Propofol - administration & dosage
Remifentanil
Respiration - drug effects
Respiratory System Agents - pharmacology
Surgery
Tidal Volume - drug effects
Total intravenous anesthesia
title Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T18%3A49%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20recovery%20and%20respiratory%20effects%20of%20aminophylline%20and%20doxapram%20following%20total%20intravenous%20anesthesia%20with%20propofol%20and%20remifentanil&rft.jtitle=Journal%20of%20clinical%20anesthesia&rft.au=Kim,%20Dae%20Woo,%20MD,%20PhD&rft.date=2013-05-01&rft.volume=25&rft.issue=3&rft.spage=173&rft.epage=176&rft.pages=173-176&rft.issn=0952-8180&rft.eissn=1873-4529&rft_id=info:doi/10.1016/j.jclinane.2012.07.005&rft_dat=%3Cproquest_cross%3E1353986455%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1355953292&rft_id=info:pmid/23583458&rft_els_id=1_s2_0_S095281801300055X&rfr_iscdi=true